Mark Aloysius Morgan, M.D.

faculty photo
John J. Mikuta, M.D. Professor of Gynecologic Oncology
Department: Obstetrics and Gynecology

Contact information
Chief, Division Of Gynecologic Oncology
University Of Pennsylvania Health System
3400 Civic Center Boulevard, 10th Floor PCAM South Tower
Philadelphia, PA 19104
Office: 215-662-3318
Fax: 215-349-5849
B.A. (Microbiology)
Rutgers College, 1977.
M.D. (Medicine)
Downstate Medical Center (SUNY) Cum Laude, 1982.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

Clinical trials

Description of Clinical Expertise

Gynecologic Oncology; Urogynecology

Selected Publications

Farley J, Brady WE, Vathipadiekal V, Lankes HA, Coleman R, Morgan MA, Mannel R, Yamada SD, Mutch D, Rodgers WH, Birrer M, Gershenson DM: Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or perineum: an open label, single-arm, phase 2 study. The Lancet 4(2):134-140, 2013.

Myers SB, Manne SL, Kissane DW, Ozga M, Kashy DA, Rubin S, Heckman C, Rosenblum N, Morgan M, Graff JJ: Social-cognitive processes associated with fear of recurrence among women newly diagnosed with gynecologic cancers. Gynecol Oncol 128(1):120-127, 2013.

Chu CS, Boyer J, Schullery DS, Gimotty PA, Gamerman V, Bender J, Levine BL, Coukos G, Rubin SC, Morgan MA, Vonderheide RH, June CH: Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission. Cancer Immunol Immunother 61(5):629-641. , 2012 Notes:

Morgan MA, Sill MW, Fujiwara K, Greer B, Rubin SC, DeGeest K, Yamada SD, Waggoner S, Coleman, RL, Walker JL, Mannel RS: A Phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in unreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group study. Gynecol Oncol 121(2):264-68, 2011 Notes: PMCID: PMC3081997/NIHMSID: NIHMS270582.

Greer BE, Koh WJ, Abu-Rustum NR, Apte SM, Campos SM, Chan J, Cho KR, Copeland L, Crispens MA, DuPont N, Eifel PJ, Gaffney DK, Huh WK, Kapp DS, Lurain JR, Martin L, Morgan MA, Morgan RJ, Mutch D, Remmenga SW, Reynolds RK, Small W, Teng N, Valea FA: Cervical Cancer. J Nat’l Compr Canc Netw 8(12):1388-416, 2010.

Greer BE, Koh WJ, Abu-Rustum N, Bookman, MA, Bristow RE, Campos SM, Cho, KR, Copeland L, Crispens MA, Eifel PJ, Huh WK, Jagernauth W, Kapp DS, Kavanagh JJ, Lurain JR 3rd, Morgan MA, Morgan RJ, Powell CB, Remmenga SW, Reynolds RK, Alvarez Secord A, Small W Jr., Teng N.: NCCN Clinical Practice Guidelines in Oncology: Uterine Neoplasms. J Natl Compr Canc Netw 7(5):498-531, 2009.

Kavanagh JJ, Sill MW, Ramirez PT, Warshal D, Pearl ML, Morgan MA: Phase II multicenter open-label study of karenitecin in previously treated epithelial ovarian and primary peritoneal cancer: A Gynecologic Oncology Group Study. Int J Gynecol Cancer 18(3):460-464, 2008.

Morgan, MA: Intraperitoneal chemotherapy for ovarian cancer. Adv Exp Med Biol 622:145-51, 2008.

Morgan MA, Darcy KM, Rose PG, DeGeest K, Bookman MA, Aikins JK, Sill MW, Mannel RS, Allievi C, Egorin MJ: Paclitaxel poliglumex and carboplatin as first-line therapy in ovarian, peritoneal or fallopian tube cancer: A phase I and feasibility trial of the Gynecologic Oncology Group. Gynecologic Oncology 110:329-335, 2008.

Morgan MA, Polan ML, Melecot HH, Debru B, Sleemi A, Husain A: Experience with a low-pressure colonic pouch (Mainz II) urinary diversion for irreparable vesicovaginal fistula and bladder extrophy in East Africa. Int Urogynecol J 20:1163-1168, 2009.

back to top
Last updated: 07/10/2020
The Trustees of the University of Pennsylvania